Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
Cash to Debt No Debt
SHP's Cash to Debt is ranked lower than
64% of the 896 Companies
in the Global Biotechnology industry.

( Industry Median: 171.30 vs. SHP: No Debt )
SHP' s 10-Year Cash to Debt Range
Min: 11.19   Max: No Debt
Current: No Debt

Interest Coverage No Debt
SHP's Interest Coverage is ranked lower than
134% of the 425 Companies
in the Global Biotechnology industry.

( Industry Median: 10000.00 vs. SHP: No Debt )
SHP' s 10-Year Interest Coverage Range
Min: 1000   Max: 1000
Current: No Debt

F-Score: 5
M-Score: -2.41
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
Operating margin (%) 8.70
SHP's Operating margin (%) is ranked lower than
73% of the 785 Companies
in the Global Biotechnology industry.

( Industry Median: -66.98 vs. SHP: 8.70 )
SHP' s 10-Year Operating margin (%) Range
Min: 8.7   Max: 16.3
Current: 8.7

8.7
16.3
Net-margin (%) 10.00
SHP's Net-margin (%) is ranked lower than
73% of the 785 Companies
in the Global Biotechnology industry.

( Industry Median: -56.37 vs. SHP: 10.00 )
SHP' s 10-Year Net-margin (%) Range
Min: 10   Max: 15
Current: 10

10
15
ROE (%) 8.40
SHP's ROE (%) is ranked lower than
70% of the 812 Companies
in the Global Biotechnology industry.

( Industry Median: -21.87 vs. SHP: 8.40 )
SHP' s 10-Year ROE (%) Range
Min: 8.4   Max: 90.5
Current: 8.4

8.4
90.5
ROA (%) 6.70
SHP's ROA (%) is ranked lower than
64% of the 894 Companies
in the Global Biotechnology industry.

( Industry Median: -18.90 vs. SHP: 6.70 )
SHP' s 10-Year ROA (%) Range
Min: 6.7   Max: 14.7
Current: 6.7

6.7
14.7
ROC (Joel Greenblatt) (%) 4.80
SHP's ROC (Joel Greenblatt) (%) is ranked lower than
65% of the 872 Companies
in the Global Biotechnology industry.

( Industry Median: -196.35 vs. SHP: 4.80 )
SHP' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 3.2   Max: 28.4
Current: 4.8

3.2
28.4
» SHP's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2012

SHP Guru Trades in Q3 2012

Jim Simons 14,700 sh (New)
» More
Q4 2012

SHP Guru Trades in Q4 2012

Jim Simons 26,224 sh (+78.39%)
» More
Q1 2013

SHP Guru Trades in Q1 2013

Jim Simons 73,646 sh (+180.83%)
» More
Q2 2013

SHP Guru Trades in Q2 2013

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SHP



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 7.81
SHP's P/B is ranked lower than
72% of the 791 Companies
in the Global Biotechnology industry.

( Industry Median: 4.46 vs. SHP: 7.81 )
SHP' s 10-Year P/B Range
Min: 0.8   Max: 2.02
Current: 7.81

0.8
2.02
P/S 1.33
SHP's P/S is ranked lower than
74% of the 771 Companies
in the Global Biotechnology industry.

( Industry Median: 10.27 vs. SHP: 1.33 )
SHP' s 10-Year P/S Range
Min: 0.91   Max: 2.66
Current: 1.33

0.91
2.66
EV-to-EBIT 24.10
SHP's EV-to-EBIT is ranked lower than
122% of the 468 Companies
in the Global Biotechnology industry.

( Industry Median: 20.00 vs. SHP: 24.10 )
SHP' s 10-Year EV-to-EBIT Range
Min: 42.5   Max: 148.5
Current: 24.1

42.5
148.5

Valuation & Return

vs
industry
vs
history
Price/Net Cash 33.10
SHP's Price/Net Cash is ranked lower than
120% of the 477 Companies
in the Global Biotechnology industry.

( Industry Median: 9.30 vs. SHP: 33.10 )
SHP' s 10-Year Price/Net Cash Range
Min: 8   Max: 34.6
Current: 33.1

8
34.6
Price/Net Current Asset Value 5.80
SHP's Price/Net Current Asset Value is ranked lower than
109% of the 525 Companies
in the Global Biotechnology industry.

( Industry Median: 9.60 vs. SHP: 5.80 )
SHP' s 10-Year Price/Net Current Asset Value Range
Min: 5.6   Max: 14.2
Current: 5.8

5.6
14.2
Price/Tangible Book 1.10
SHP's Price/Tangible Book is ranked lower than
78% of the 736 Companies
in the Global Biotechnology industry.

( Industry Median: 6.00 vs. SHP: 1.10 )
SHP' s 10-Year Price/Tangible Book Range
Min: 1   Max: 1.9
Current: 1.1

1
1.9
Price/Median PS Value 0.70
SHP's Price/Median PS Value is ranked lower than
79% of the 725 Companies
in the Global Biotechnology industry.

( Industry Median: 1.10 vs. SHP: 0.70 )
SHP' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 1.5
Current: 0.7

0.6
1.5

Business Description

Industry: Biotechnology » Biotechnology
Compare: » details
» More Articles for NYSE:SHP

Headlines

Articles On GuruFocus.com
No related article found.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide